Longevity and Anti-senescence Therapy Market, By Therapy (Senolytic Drug Therapy, Gene Therapy, Immunotherapy, and Others), By Application (Longevity, Senescence Inhibition, Cardiovascular Diseases, Neural Degenerative Diseases, Ophthalmology Disorders, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI421020 | Publish Date: June 2023 | No. of Pages: 170

Global Longevity And Anti Senescence Therapy Market Overview

Aging is a process of losing physiological integrity and function over time. Changes in gene expression that occurs naturally during an organismal lifespan without altering the DNA sequence is referred to as aging epigenetics. Anti-aging therapy has various application such as it’s used to decrease the production of free radicals. Further, it is used to increase skin elasticity by supplementing antioxidant substances, along with supplementing collagen or enzyme. Moreover, anti-aging skin care products and anti-aging dietary therapy can effectively delay aging.Longevity and Anti-senescence Therapy Market accounted for US$ 165.6 Million in 2019 and is estimated to be 857.7 Million by 2029 and is anticipated to register a CAGR of 17.7%

Global Longevity And Anti Senescence Therapy Market Dynamics

Growing geriatric population globally

Geriatric population of world continues to grow at an unprecedented rate. According to data published in– ‘An Aging World: 2015’, the percentage of aging population is expected to jump to nearly 17% of the world’s population by 2050 (1.6 billion). Further, as per the data reported by National Institutes of Health, America’s 65-and-over population is estimated to almost double over the next three decades, from 48 million to 88 million by 2050. The global population of the people aged 80 and older is projected to increase at triple rate between 2015 and 2050, rising from 126.5 million to 446.6 million. The population in countries like Asia and Latin America is projected to quadruple by 2050.

Increasing awareness regarding Antiaging Products among Generation Y and Later Generations

Anti-wrinkle products have formulation well matched to slower the aging process and thus are gaining traction globally. Main causes of wrinkles involves dehydration, absence of essential nutrients in the body, exposure to pollution for higher duration and UV light, smoking, and drugs, along with other genetic factors. Greater prominence of appearance and higher aging anxiety are related to superior likelihood of buying anti-aging products.

Additionally, rising advancements in anti-senescence technologies and surging level of disposable income are also gaining traction in the target market. Furthermore, surging demand for cell-based assays in research and development and growing prominence on stem cell research is likely to gain significant impetus for the longevity and anti-senescence therapy market share over the forecast period.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Longevity And Anti Senescence Therapy Market Segmentation

The global longevity and anti-senescence therapy market is segmented based on therapy, application, and region.

On the basis of therapy, the global longevity and anti-senescence therapy market is segmented into senolytic drug therapy, gene therapy, immunotherapy, and others. Based on application, the target market is segmented into longevity, senescence inhibition, cardiovascular diseases, neural degenerative diseases, ophthalmology disorders, and others.

Regional Insights:

On region the global longevity and anti-senescence therapy market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for major share of the global longevity & anti-senescence therapy market throughout the forecast period. Increase in prevalence of obesity & cardiovascular diseases, structured reimbursement policies, developed health care infrastructure, and continuous research activities in developing advanced technologies leads to expand the North America market in the near future at a rapid pace. Asia Pacific longevity & anti-senescence therapy market is valued to grow at a rapid pace in the coming years. This can be credited due to rising trend of protective health care measures in North America.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Attribute

Details

Base year for estimation

2019

Forecast period

2019 – 2029

Market representation

Revenue in USD Million & CAGR from 2019 to 2029

Market Segmentation

By Product Type- Senolytic Drug Therapy, Gene Therapy, Immunotherapy, and Others

By Application – Longevity, Senescence Inhibition, Cardiovascular Diseases, Neural Degenerative Diseases, Ophthalmology Disorders, and Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global longevity and anti-senescence therapy market report based on therapy, application, and region:

Global Longevity and Anti-senescence Therapy Market, By Therapy:

  • Senolytic Drug Therapy
  • Gene Therapy
  • Immunotherapy
  • Others

Global Longevity and Anti-senescence Therapy Market, By Application:

  • Longevity
  • Senescence Inhibition
  • Cardiovascular Diseases
  • Neural Degenerative Diseases
  • Ophthalmology Disorders
  • Others

Global Longevity and Anti-senescence Therapy Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Longevity And Anti Senescence Therapy Market Key Players

The key players operating the global longevity and anti-senescence therapy market includes Acorda Therapeutics, Human Longevity Inc., Calico Life Sciences, Insilico Medicine, Oisin Biotechnology, Recursion Pharmaceuticals, Restorbio, Proteostasis Therapeutics Inc., Senex Biotechnology, and Senolytic Therapeutics. The major market companies operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market. For instance, in January 2020, Human Longevity, Inc., a leader in offering data-driven health intelligence and accuracy health to physicians and patients, announced the acquisition of DoctorsForMe, Inc. The procurement helps clients of Human Longevity to access world-class services and physicians of Mass General, well trusted by patients globally as one of the best hospitals in the world.

Global Longevity And Anti Senescence Therapy Market Company Profile

  • Acorda Therapeutics
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Human Longevity Inc.
  • Calico Life Sciences
  • Insilico Medicine
  • Oisin Biotechnology
  • Recursion Pharmaceuticals
  • Restorbio
  • Proteostasis Therapeutics Inc.
  • Senex Biotechnology
  • Senolytic Therapeutics

 “*” marked represents similar segmentation in other categories in the respective section

Global Longevity And Anti Senescence Therapy Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Longevity and Anti-senescence Therapy Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Therapy
      • Market Snippet, By Application
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Longevity and Anti-senescence Therapy Market, By Therapy, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Senolytic Drug Therapy
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Gene Therapy
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Immunotherapy
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Longevity and Anti-senescence Therapy Market, By Application, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Longevity
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Senescence Inhibition
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cardiovascular Diseases
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Neural Degenerative Diseases
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Ophthalmology Disorders
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Longevity and Anti-senescence Therapy Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Therapy, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Therapy, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Therapy, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Therapy, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size  and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Therapy, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  9. Company Profiles
      • Acorda Therapeutics
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Business Strategies
      • Human Longevity Inc.
      • Calico Life Sciences
      • Insilico Medicine
      • Oisin Biotechnology
      • Recursion Pharmaceuticals
      • Restorbio
      • Proteostasis Therapeutics Inc.
      • Senex Biotechnology
      • Senolytic Therapeutics
  10. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The longevity and anti-senescence therapy market accounted for US$ 165.6 Million in 2019 and is estimated to be 857.7 Million by 2029 and is anticipated to register a CAGR of 17.7%.

The market report has been segmented on the basis of therapy, application, and region.

the development of novel anti-aging therapies, the focus on personalized and precision medicine for longevity, and advancements in regenerative medicine, presenting significant opportunities in the global Longevity and Anti-senescence Therapy Market.

increasing focus on preventive healthcare, advancements in biotechnology and genomics, and the rising demand for interventions to address age-related conditions.

North America, Europe, and Asia-Pacific are likely to be key regions, but the situation is dynamic, and it's advisable to refer to the latest reports for the most current information.

The prominent player operating in the global longevity and anti-senescence therapy market includes Acorda Therapeutics, Human Longevity Inc., Calico Life Sciences, Insilico Medicine, Oisin Biotechnology, Recursion Pharmaceuticals, Restorbio, Proteostasis Therapeutics Inc., Senex Biotechnology, and Senolytic Therapeutics